AU2001260633A1 - Fas ligand-fused proteins - Google Patents

Fas ligand-fused proteins

Info

Publication number
AU2001260633A1
AU2001260633A1 AU2001260633A AU6063301A AU2001260633A1 AU 2001260633 A1 AU2001260633 A1 AU 2001260633A1 AU 2001260633 A AU2001260633 A AU 2001260633A AU 6063301 A AU6063301 A AU 6063301A AU 2001260633 A1 AU2001260633 A1 AU 2001260633A1
Authority
AU
Australia
Prior art keywords
fas ligand
fused proteins
fused
proteins
fas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260633A
Inventor
Jyunko Touma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of AU2001260633A1 publication Critical patent/AU2001260633A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001260633A 2000-05-26 2001-05-28 Fas ligand-fused proteins Abandoned AU2001260633A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-156209 2000-05-26
JP2000156209 2000-05-26
PCT/JP2001/004456 WO2001090382A2 (en) 2000-05-26 2001-05-28 Fas ligand-fused proteins

Publications (1)

Publication Number Publication Date
AU2001260633A1 true AU2001260633A1 (en) 2001-12-03

Family

ID=18661029

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260633A Abandoned AU2001260633A1 (en) 2000-05-26 2001-05-28 Fas ligand-fused proteins

Country Status (6)

Country Link
US (1) US20040053249A1 (en)
EP (1) EP1365027A4 (en)
JP (1) JPWO2001090382A1 (en)
AU (1) AU2001260633A1 (en)
CA (1) CA2410525A1 (en)
WO (1) WO2001090382A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004022599A1 (en) * 2002-08-22 2005-12-22 株式会社ペプタイドドア Fusion antibody and method for producing the same
WO2005012363A1 (en) * 2003-08-01 2005-02-10 Mochida Pharmaceutical Co., Ltd. Targeting inflammation inducer
EP1778725B1 (en) 2004-07-23 2010-12-29 Novartis Vaccines and Diagnostics S.r.l. Polypeptides for oligomeric assembly of antigens
AU2006279541A1 (en) 2005-08-15 2007-02-22 The Regents Of The University Of California VEGF-activated FAS ligands
EP1894940A1 (en) * 2006-08-28 2008-03-05 Apogenix GmbH TNF superfamily fusion proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716805A (en) * 1991-10-25 1998-02-10 Immunex Corporation Methods of preparing soluble, oligomeric proteins
IL122174A (en) * 1995-06-07 2004-07-25 Immunex Corp Dna encoding a cd40l mutein and a cd40l polypeptide encoded by said dna
US6001962A (en) * 1996-11-15 1999-12-14 The Regents Of The University Of California Modified Fas ligands
DE19963859A1 (en) * 1999-12-30 2001-07-12 Apotech Res & Dev Ltd Bi- or oligomer of a di-, tri-, quattro- or pentamer of recombinant fusion proteins

Also Published As

Publication number Publication date
CA2410525A1 (en) 2001-11-29
WO2001090382A2 (en) 2001-11-29
EP1365027A4 (en) 2005-06-22
JPWO2001090382A1 (en) 2004-04-30
WO2001090382A3 (en) 2003-09-12
EP1365027A2 (en) 2003-11-26
US20040053249A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
AU2001291049A1 (en) Defensin-antigen fusion proteins
AU6045900A (en) Interaction-activated proteins
AU2002233994A1 (en) Secreted proteins
AU2001270045A1 (en) Secreted proteins
AU2001255320A1 (en) Secreted proteins
AU2001240791A1 (en) Sequence
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2001259450A1 (en) Cytoskeleton-associated proteins
AU2001260633A1 (en) Fas ligand-fused proteins
AU2002216100A1 (en) Dormancy - induced mycobacterium proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001282521A1 (en) OCT preparations
AU2001244863A1 (en) Apoptin-associating protein
AU2001229366A1 (en) Secreted proteins
AU2002240889A1 (en) Proteins that interact with betatrcp
AU2001241044A1 (en) Mitf-associated proteins
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2001278777A1 (en) Irap-binding protein
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001284748A1 (en) Reaper protein
AU2001295042A1 (en) Anti-stilbene antibodies
AU2001263445A1 (en) Methods for protein design
AU2001277614A1 (en) Novel proteins
AU2002326909A1 (en) Neurotransmission-associated proteins
AU2002357873A1 (en) Carbohydrate-associated proteins